Lightbloom

May 2026

The Operations Brief

Getz Pharma

Three opportunities to reduce operational overhead as Getz scales its global footprint. A starting point for what we believe is a larger conversation.

By Lightbloom · An AI Operating Partner

Potential savings: €1.6-2.5M per year

CY2022 to CY2024e · three years of consistent growth

~€315M

CY2024e revenue

9MCY24 PKR 74bn · +29% YoY · PACRA confirmed

13,500

Product-country registrations

300 products · 45 markets

Revenue up 31% in CY2023 and continuing at 29% through the first nine months of 2024. The operational complexity running beneath that growth has not been systematically redesigned to match it.

Fig. 1 · Annual revenue · EUR million · CY2022-CY2024e

€189M (CY2022) to €248M (CY2023, PACRA confirmed) to ~€315M (CY2024e, extrapolated from 9MCY24 PKR 74bn at +29% YoY). CY2024 full-year not yet published. PKR converted at 310.

Getz Pharma is Pakistan's largest pharmaceutical company by market share and its largest pharmaceutical exporter for nineteen consecutive years, a record recognised at a national ceremony by the Prime Minister in February 2026. Revenue grew 31% in CY2023 to PKR 76.8bn and continued at 29% through the first nine months of 2024, putting the full-year CY2024 run rate at approximately €315M. In October 2025, Getz became the first company globally to launch the complete range of GLP-1 and GIP receptor agonist biosimilar therapies. It runs on SAP ERP and SAP EWM. The back-office infrastructure supporting a €315M and growing business is largely manual at the points where it matters most.

Three key opportunities identified.

Assembled from public sources only: PACRA rating reports, Getz Pharma's website, WHO prequalification database, and press coverage. Lightbloom has seen no internal data.

What is visible from the outside is typically 40-60% of what a full operational review surfaces once we have access to SAP purchase order data, actual regulatory headcount, and process detail. The opportunities below are conservative and defensible from public evidence. The picture from inside is larger.

1

Opportunity One

Pay the API market, not the relationship

How a procurement intelligence AI agent reads SAP purchase history against live Indian and Chinese API benchmarks, recovering four years of price drift on a PKR 39bn raw material base.

Finding

Getz manufactures 300+ branded generic formulations, each requiring one or more Active Pharmaceutical Ingredients sourced predominantly from India and China. SAP ERP records every purchase order: molecule, supplier, quantity, price, date. Indian API prices fluctuate with feedstock costs, capacity utilisation, and global demand. The price Getz locked in six months ago for a given molecule may differ by 15-30% from what is available today. On a CY2024e raw material spend of approximately PKR 39bn (40% of ~PKR 97bn estimated revenue), even a modest systematic recovery rate produces material value. Without a benchmarking process running continuously against current market rates, price movements are captured opportunistically rather than systematically.

The price was right at negotiation. The market has moved since, molecule by molecule, without anyone tracking it.

Our Solution

An AI procurement intelligence agent ingests Getz's SAP purchase order history by molecule and supplier, normalises for pack size and purity specifications, and cross-references against live API pricing from Indian and Chinese manufacturer databases. Three outputs: molecules where Getz is paying above the current market benchmark (renegotiation candidates); molecules sourced from a single supplier where dual-sourcing options exist at lower cost; and consolidated buying opportunities where multiple Getz products share an API and volumes could be bundled. Procurement keeps the relationships. The AI agent keeps the market in view. The top 20-30 molecules by spend account for 70-80% of the total savings potential. That is where it starts.

Estimated annual value

01 / 03

€900K-1.4M

per year

PKR 38.8bn API/raw material base x 60% addressable (non-captive, non-DRAP-locked molecules) = PKR 23.3bn. AI-assisted benchmarking recovery at 1.5-2.5% of addressable spend in year one = PKR 349-582M. Conservative range at PKR 280-430M = €900K-1.4M, reflecting year-one capture rate and active short-term contracts.

2

Opportunity Two

See the network, not the shipments

How a distributor analytics and freight audit AI agent reads SAP outbound data against carrier benchmarks, surfacing inventory, consolidation, and modal opportunities across 45 export markets.

Finding

Getz distributes 300+ products domestically across Pakistan and exports to 45 countries from its Karachi facility. CY2023 export revenue was PKR 23.9bn, PACRA confirmed, representing 31% of group revenue. Through 9MCY24, export share held steady at approximately 30% of PKR 74bn, implying ~PKR 22.2bn in nine-month export revenue. SAP EWM manages the warehouse side. Across this combined domestic and export footprint, freight is purchased mostly on a transaction-by-transaction or annual-contract basis without the kind of AI-assisted benchmarking that systematically identifies where consolidation, modal shift, or distributor replenishment optimisation would reduce cost. In domestic distribution, the consistent inefficiency for Pakistani pharmaceutical manufacturers is the disconnect between what Getz ships to distributors and what distributors actually sell to pharmacies. Without granular secondary sales data feeding production planning, decisions run against distributor order patterns rather than end-market demand.

45 markets. Freight priced one shipment at a time, distributor inventory managed one order at a time.

Our Solution

A distributor performance and secondary sales AI agent reads SAP outbound data against distributor sell-through reports (or proxy demand signals) and flags distributors running high inventory relative to sales velocity, markets losing shelf presence due to supply inconsistency, and production planning signals that reduce over-ordering. For export freight, an AI freight audit tool reviews all international shipments against carrier market rates, identifies consolidation opportunities on lanes where shipments go to the same region within close time windows, and flags where airfreight is handling shipments that cold-chain sea freight could serve at lower cost. Both tools are read-only and advisory. Supply chain keeps the decisions.

Estimated annual value

02 / 03

€390-630K

per year

Domestic distribution cost estimated at 8% of domestic revenue (PKR 67.9bn x 8% = PKR 5.43bn). Route and inventory optimisation at 2-3% recovery = PKR 109-163M. Export freight estimated at 6% of PKR 29.1bn export revenue = PKR 1.75bn. Freight audit at 3-5% recovery = PKR 52-87M. Total PKR 161-250M; conservative range at PKR 120-195M = €390-630K.

3

Opportunity Three

Draft the dossier, not the document factory

How a regulatory document preparation AI agent pulls QMS and SAP data into country-format submission drafts, reducing preparation time per dossier from 8-15 hours to 2-4.

Finding

Getz holds product registrations across 45 export markets for a portfolio of 300+ products. Each registration requires an initial regulatory dossier, periodic renewal submissions on 5-year cycles, and variation submissions whenever a formulation, packaging, or API supplier changes. Across 45 countries and 300 products, the theoretical registration universe is 13,500 product-country combinations. Assume 30% are active at any time and the regulatory team is managing approximately 4,000 live registrations with continuous renewal and variation activity. Regulatory dossier preparation is overwhelmingly a document assembly task: pulling Certificates of Analysis, stability data, and manufacturing site files from the quality management system and SAP, and formatting them into country-specific templates that already exist. This is where the time goes, not in the regulatory judgment itself.

4,000 active registrations. The data to populate each dossier already exists in the QMS. It just is not queryable.

Our Solution

A regulatory document preparation AI agent pulls the required data elements from Getz's QMS and SAP for each submission, populates the relevant country-format dossier template (CTD, ACTD, WHO, local format), and outputs a near-complete draft for the regulatory affairs officer to review. Preparation time per dossier falls from an estimated 8-15 hours to 2-4. A registration status tracking system maintains the renewal calendar across all 45 markets, alerting the team six months before each deadline. The AI agent handles the assembly. Regulatory judgment stays entirely with the qualified regulatory affairs professional. Every output is reviewed and approved before submission.

Estimated annual value

03 / 03

€320-470K

per year

150-200 regulatory/quality FTE at PKR 120K/month: PKR 216-288M/year. 30-35% workload reduction via document automation, converting to 40-50 FTE natural attrition over 24 months = PKR 57-72M/year = €186-232K. External regulatory agent spend reduced by 30% on $400-700K estimated base = €111-194K. Total PKR 100-145M = €320-470K.

Before anything else

We validate the numbers first. Then we build.

Nothing here becomes a commitment until the math is validated against Getz's actual SAP and QMS data. If the numbers hold, Lightbloom builds the fixes specific to Getz's stack. They are AI agent workflows running on Yield, the AI operating platform we build and use internally, and they keep running. We earn 20% of Confirmed Annual Value per opportunity, once, after the savings land in Getz's accounts. Nothing before that.

  1. Week 1

    01 / 04

    SAP and QMS landing

    Read-only extraction from SAP ERP, SAP EWM, and the quality management system. Data quality assessed against all three opportunity workstreams. No process changes proposed yet.

  2. Week 2

    02 / 04

    Top-30 API benchmark

    Pull the last 24 months of purchase orders for the top 30 molecules by spend. Cross-reference against current Indian and Chinese manufacturer pricing. Rank outliers by annual saving if benchmark is achieved.

  3. Week 3

    03 / 04

    Registration map and five-market pilot

    Pick five export markets and ten products. Map current dossier preparation time, identify the data that already lives in QMS and SAP, and prototype one populated template to validate the approach.

  4. Week 4

    04 / 04

    Joint readout · commitment

    Baseline validated against Getz's actual books. Scope and sequencing of the build agreed. The engagement begins or it does not. Both ends are honest.

Together, three opportunities

Opportunity One

€900K-1.4M

Opportunity Two

€390-630K

Opportunity Three

€320-470K

· sum ·

€1.6-2.5M

per year, recurring

Identifiable from public sources only. The four weeks will confirm whether it holds. Internal access reveals what public sources cannot.

Where this goes next

A thirty-minute call. Nothing more until it is mutual.

We walk through the brief together: your reactions, what we got wrong, what we missed. If the four-week diagnostic still makes sense at the end, we scope it. If not, we shake hands. Lightbloom only earns when Getz does.